Nomura discloses 807,923 CRL shares, 1.6% ownership (13G/A)

Charles River Laboratories (CRL): Schedule 13G/A reports that Nomura Holdings, Inc. beneficially owns 807,923 shares of CRL common stock, equal to 1.6% of the class.

Accepted by SEC EDGAR 11/14/2025 - 04:57 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Charles River Laboratories (CRL): Schedule 13G/A reports that Nomura Holdings, Inc. beneficially owns 807,923 shares of CRL common stock, equal to 1.6% of the class. The ownership is held with sole voting and dispositive power and is attributed to Nomura subsidiaries Nomura Global Financial Products, Inc., Nomura Securities International, Inc., and Nomura International PLC.

The percentage is based on 49,215,000 shares outstanding as of September 27, 2025. Nomura certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Nomura disclose in its Schedule 13G/A for CRL?

Nomura Holdings, Inc. reported beneficial ownership of 807,923 CRL shares, representing 1.6% of the outstanding common stock.

How was the 1.6% ownership in CRL calculated?

It was calculated using 49,215,000 shares outstanding as of September 27, 2025, as reported by the issuer.

Does Nomura have voting and dispositive power over the CRL shares?

Yes. Nomura reports sole voting power and sole dispositive power over 807,923 shares.

Which Nomura subsidiaries hold the CRL shares?

Shares are beneficially owned by NGFP (806,275), NSI (468), and NIP (1,180), all wholly owned by Nomura Holdings, Inc.

What certification did Nomura include about its CRL holdings?

Nomura certified the shares were acquired and are held in the ordinary course of business and not to influence control.

What is the date of the event requiring this filing?

The event date is September 30, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

(Name of Issuer)

Common Stock, $0.01 par value per share

(Title of Class of Securities)

159864107

(CUSIP Number)

09/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 159864107

1

Names of Reporting Persons

NOMURA HOLDINGS INC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

JAPAN

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 807,923.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 807,923.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

807,923.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

1.6 %

12

Type of Reporting Person (See Instructions)

HC

Comment for Type of Reporting Person: (1) Sole voting and dispositive power represents (i) 806,275 shares of Common Stock beneficially owned by Nomura Global Financial Products, Inc. ("NGFP"), (ii) 468 shares of Common Stock beneficially owned by Nomura Securities International, Inc. ("NSI"), and (iii) 1,180 shares of Common Stock beneficially owned by Nomura International PLC ("NIP"). NGFP, NSI and NIP are wholly owned subsidiaries of Nomura Holdings, Inc., which accordingly may be deemed to beneficially own the shares of Common Stock beneficially owned by NGFP, NSI and NIP. (2) The percent of class is calculated based on 49,215,000 shares of Common Stock outstanding as of September 27, 2025, as reported in the Issuer's quarterly report on Form 10-Q for the fiscal quarter ended September 27, 2025 filed with the SEC on November 5, 2025.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
(b)	Address of issuer's principal executive offices: 251 Ballardvale Street, Wilmington, Massachusetts, 01887
Item 2.
(a)	Name of person filing: Nomura Holdings, Inc.
(b)	Address or principal business office or, if none, residence: Nomura Holdings, Inc.: 13-1, Nihonbashi 1-chome, Chuo-ku, Tokyo 103-8645, Japan
(c)	Citizenship: Nomura Holdings, Inc.: Japan
(d)	Title of class of securities: Common Stock, $0.01 par value per share
(e)	CUSIP No.: 159864107
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Items 5-11 of the cover page are incorporated by reference.
(b)	Percent of class: Items 5-11 of the cover page are incorporated by reference.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Items 5-11 of the cover page are incorporated by reference.
	(ii) Shared power to vote or to direct the vote: Items 5-11 of the cover page are incorporated by reference.
	(iii) Sole power to dispose or to direct the disposition of: Items 5-11 of the cover page are incorporated by reference.
	(iv) Shared power to dispose or to direct the disposition of: Items 5-11 of the cover page are incorporated by reference.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit A
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

NOMURA HOLDINGS INC

Signature:	/s/ Samir Patel
Name/Title:	Samir Patel, Managing Director
Date:	11/14/2025

Exhibit Information

Exhibit A - Subsidiaries